Gary Edelson is an Endocrinology/Metabolic physician affiliated with Oakland University. OpenAlex indexes 21 publications with 418 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
32255 Northwestern Hwy Ste 214
Farmington Hills, MI 48334
Telephone
248-855-5620Registry record last updated 30 May 2018.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis Pharma Endocrinology IncProgram year2025118 payments$73,089openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202570 payments$27,768openpaymentsdata.cms.gov ↗
- Corcept TherapeuticsProgram year202526 payments$14,999openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
63.9%l-Thyroxine59.7%Levothyroxine Sodium77%Synthroid18%Levoxyl4%Unithroid1%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.4%Methimazole100%Part D≥17 patients+ 3 more classes in this area
Metabolism & gastrointestinal
24.7%GLP-1 receptor agonist7.2%Ozempic49%Mounjaro29%Trulicity22%Part D<11 patientsSGLT2 inhibitor4.1%Jardiance71%Farxiga29%Part D<11 patients+ 7 more classes in this area
Genitourinary & hormones
4.1%Androgen2.3%Testosterone100%Part D≥21 patientsEstrogen Agonist/Antagonist1.8%Raloxifene Hcl100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Low Bone Mass Due to Hypoestrogenism in a Patient with Hypoestrogenism in a Patient with Carbohydrate Deficient Glycoprotein Syndrome
Journal of Clinical Densitometry
2006 - Abstract supplement: From the 2004 ISCD Annual Scientific Meeting January 28–31, Miami, FL
Journal of Clinical Densitometry
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Alon Kahana, MD
Oakland University
Mitchell Cappell, MD
Oakland University
Thomas Schwann, MD
Oakland University
Laith Jamil, MD
Oakland University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”